Literature DB >> 15250040

Towards an understanding of organic anion transporters: structure-function relationships.

Guofeng You1.   

Abstract

Organic anion transporters (OAT) play essential roles in the body disposition of clinically important anionic drugs, including anti-viral drugs, anti-tumor drugs, antibiotics, anti-hypertensives, and anti-inflammatories. The activities of OATs are directly linked to drug toxicity and drug-drug interactions. So far, four members of the OAT family have been identified: OAT1, OAT2, OAT3, and OAT4. These transporters share several common structural features including 12 transmembrane domains, multiple glycosylation sites localized in the first extracellular loop between transmembrane domains 1 and 2, and multiple phosphorylation sites present in the intracellular loop between transmembrane domains 6 and 7, and in the carboxyl terminus. The impact of these structural features on the function of these transporters has just begun to be explored. In the present review, the author will summarize recent progress made from her laboratory as well as from others, on the molecular characterization of the structure-function relationships of OATs, including particular amino acid residues/regions of the transporter protein ("molecular domains") that potentially determine transport characteristics. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250040     DOI: 10.1002/med.20014

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  18 in total

1.  Accumulation of non-steroidal anti-inflammatory drugs by gingival fibroblasts.

Authors:  M M Zavarella; O Gbemi; J D Walters
Journal:  J Dent Res       Date:  2006-05       Impact factor: 6.116

2.  Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation.

Authors:  Yi-Tzai Chen; Lynnie Trzoss; Dongfang Yang; Bingfang Yan
Journal:  Toxicology       Date:  2015-02-24       Impact factor: 4.221

Review 3.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

4.  Regulation of human organic anion transporter 3 by peptide hormone bradykinin.

Authors:  Shanshan Li; Peng Duan; Guofeng You
Journal:  J Pharmacol Exp Ther       Date:  2010-03-18       Impact factor: 4.030

5.  Determination of the external loops and the cellular orientation of the N- and the C-termini of the human organic anion transporter hOAT1.

Authors:  Mei Hong; Kunihiko Tanaka; Zui Pan; Jianjie Ma; Guofeng You
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

6.  Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.

Authors:  Ling Zou; Adrian Stecula; Anshul Gupta; Bhagwat Prasad; Huan-Chieh Chien; Sook Wah Yee; Li Wang; Jashvant D Unadkat; Simone H Stahl; Katherine S Fenner; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2018-05-02       Impact factor: 4.436

7.  Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway.

Authors:  Qiang Zhang; Mei Hong; Peng Duan; Zui Pan; Jianjie Ma; Guofeng You
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

8.  An Essential Role of Nedd4-2 in the Ubiquitination, Expression, and Function of Organic Anion Transporter-3.

Authors:  Da Xu; Haoxun Wang; Guofeng You
Journal:  Mol Pharm       Date:  2015-12-22       Impact factor: 4.939

9.  Novobiocin is a potent inhibitor for human organic anion transporters.

Authors:  Peng Duan; Guofeng You
Journal:  Drug Metab Dispos       Date:  2009-03-12       Impact factor: 3.922

10.  Regulation of human organic anion transporter 1 by ANG II: involvement of protein kinase Calpha.

Authors:  Shanshan Li; Peng Duan; Guofeng You
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.